314 related articles for article (PubMed ID: 22475741)
1. Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis.
Alexander JA; Jung KW; Arora AS; Enders F; Katzka DA; Kephardt GM; Kita H; Kryzer LA; Romero Y; Smyrk TC; Talley NJ
Clin Gastroenterol Hepatol; 2012 Jul; 10(7):742-749.e1. PubMed ID: 22475741
[TBL] [Abstract][Full Text] [Related]
2. Randomized controlled trial comparing aerosolized swallowed fluticasone to esomeprazole for esophageal eosinophilia.
Moawad FJ; Veerappan GR; Dias JA; Baker TP; Maydonovitch CL; Wong RK
Am J Gastroenterol; 2013 Mar; 108(3):366-72. PubMed ID: 23399553
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Budesonide vs Fluticasone for Initial Treatment of Eosinophilic Esophagitis in a Randomized Controlled Trial.
Dellon ES; Woosley JT; Arrington A; McGee SJ; Covington J; Moist SE; Gebhart JH; Tylicki AE; Shoyoye SO; Martin CF; Galanko JA; Baron JA; Shaheen NJ
Gastroenterology; 2019 Jul; 157(1):65-73.e5. PubMed ID: 30872104
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis.
Konikoff MR; Noel RJ; Blanchard C; Kirby C; Jameson SC; Buckmeier BK; Akers R; Cohen MB; Collins MH; Assa'ad AH; Aceves SS; Putnam PE; Rothenberg ME
Gastroenterology; 2006 Nov; 131(5):1381-91. PubMed ID: 17101314
[TBL] [Abstract][Full Text] [Related]
5. Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis.
Straumann A; Conus S; Degen L; Frei C; Bussmann C; Beglinger C; Schoepfer A; Simon HU
Clin Gastroenterol Hepatol; 2011 May; 9(5):400-9.e1. PubMed ID: 21277394
[TBL] [Abstract][Full Text] [Related]
6. Efficacy, dose reduction, and resistance to high-dose fluticasone in patients with eosinophilic esophagitis.
Butz BK; Wen T; Gleich GJ; Furuta GT; Spergel J; King E; Kramer RE; Collins MH; Stucke E; Mangeot C; Jackson WD; O'Gorman M; Abonia JP; Pentiuk S; Putnam PE; Rothenberg ME
Gastroenterology; 2014 Aug; 147(2):324-33.e5. PubMed ID: 24768678
[TBL] [Abstract][Full Text] [Related]
7. Comparison of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis.
Peterson KA; Thomas KL; Hilden K; Emerson LL; Wills JC; Fang JC
Dig Dis Sci; 2010 May; 55(5):1313-9. PubMed ID: 19533356
[TBL] [Abstract][Full Text] [Related]
8. Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial.
Dohil R; Newbury R; Fox L; Bastian J; Aceves S
Gastroenterology; 2010 Aug; 139(2):418-29. PubMed ID: 20457157
[TBL] [Abstract][Full Text] [Related]
9. Subepithelial collagen deposition, profibrogenic cytokine gene expression, and changes after prolonged fluticasone propionate treatment in adult eosinophilic esophagitis: a prospective study.
Lucendo AJ; Arias A; De Rezende LC; Yagüe-Compadre JL; Mota-Huertas T; González-Castillo S; Cuesta RA; Tenias JM; Bellón T
J Allergy Clin Immunol; 2011 Nov; 128(5):1037-46. PubMed ID: 21880354
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial.
Lucendo AJ; Miehlke S; Schlag C; Vieth M; von Arnim U; Molina-Infante J; Hartmann D; Bredenoord AJ; Ciriza de Los Rios C; Schubert S; Brückner S; Madisch A; Hayat J; Tack J; Attwood S; Mueller R; Greinwald R; Schoepfer A; Straumann A;
Gastroenterology; 2019 Jul; 157(1):74-86.e15. PubMed ID: 30922997
[TBL] [Abstract][Full Text] [Related]
11. Budesonide Oral Suspension Improves Symptomatic, Endoscopic, and Histologic Parameters Compared With Placebo in Patients With Eosinophilic Esophagitis.
Dellon ES; Katzka DA; Collins MH; Hamdani M; Gupta SK; Hirano I;
Gastroenterology; 2017 Mar; 152(4):776-786.e5. PubMed ID: 27889574
[TBL] [Abstract][Full Text] [Related]
12. Swallowed Fluticasone Propionate Is an Effective Long-Term Maintenance Therapy for Children With Eosinophilic Esophagitis.
Andreae DA; Hanna MG; Magid MS; Malerba S; Andreae MH; Bagiella E; Chehade M
Am J Gastroenterol; 2016 Aug; 111(8):1187-97. PubMed ID: 27325220
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of fluticasone furoate 110 microg once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen.
Jacobs R; Martin B; Hampel F; Toler W; Ellsworth A; Philpot E
Curr Med Res Opin; 2009 Jun; 25(6):1393-401. PubMed ID: 19419338
[TBL] [Abstract][Full Text] [Related]
14. Comparison of patient preference for sensory attributes of fluticasone furoate or fluticasone propionate in adults with seasonal allergic rhinitis: a randomized, placebo-controlled, double-blind study.
Meltzer EO; Andrews C; Journeay GE; Lim J; Prillaman BA; Garris C; Philpot E
Ann Allergy Asthma Immunol; 2010 Apr; 104(4):331-8. PubMed ID: 20408344
[TBL] [Abstract][Full Text] [Related]
15. An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis.
Assa'ad AH; Gupta SK; Collins MH; Thomson M; Heath AT; Smith DA; Perschy TL; Jurgensen CH; Ortega HG; Aceves SS
Gastroenterology; 2011 Nov; 141(5):1593-604. PubMed ID: 21835135
[TBL] [Abstract][Full Text] [Related]
16. Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen.
Fokkens WJ; Jogi R; Reinartz S; Sidorenko I; Sitkauskiene B; van Oene C; Faris MA; Ellsworth A; Caldwell MF
Allergy; 2007 Sep; 62(9):1078-84. PubMed ID: 17686111
[TBL] [Abstract][Full Text] [Related]
17. Eosinophilic esophagitis in adults: clinical, endoscopic, histologic findings, and response to treatment with fluticasone propionate.
Remedios M; Campbell C; Jones DM; Kerlin P
Gastrointest Endosc; 2006 Jan; 63(1):3-12. PubMed ID: 16377308
[TBL] [Abstract][Full Text] [Related]
18. Serum eosinophil cationic protein is superior to mast cell tryptase as marker for response to topical corticosteroid therapy in eosinophilic esophagitis.
Schlag C; Pfefferkorn S; Brockow K; Haller B; Slotta-Huspenia J; Schulz S; von Werder A; Ring J; Schmid RM; Bajbouj M
J Clin Gastroenterol; 2014 Aug; 48(7):600-6. PubMed ID: 24177377
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic end points in eosinophilic esophagitis: is elimination of esophageal eosinophils enough?
Hirano I
Clin Gastroenterol Hepatol; 2012 Jul; 10(7):750-2. PubMed ID: 22366179
[No Abstract] [Full Text] [Related]
20. Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial.
Rand C; Bilderback A; Schiller K; Edelman JM; Hustad CM; Zeiger RS;
J Allergy Clin Immunol; 2007 Apr; 119(4):916-23. PubMed ID: 17349681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
